Literature DB >> 9790592

Ribonuclease-charged vector for facile direct cloning with positive selection.

S M Deyev1, S A Yazynin, D A Kuznetsov, M Jukovich, R W Hartley.   

Abstract

Plasmid vectors for positive selection of cloned inserts in Escherichia coli were devised, based on an expression plasmid (pMT416) for the bacterial ribonuclease barnase. In addition to the barnase gene under control of a synthetic tac promoter, these plasmids carry the gene for the barnase inhibitor, barstar, the constitutive expression of which protects the bacterium from the detrimental effects of moderate barnase production. Full expression of the barnase gene overcomes protection by barstar and becomes lethal. Having a unique SmaI/XmaI site in the barnase structural gene, pMT416 itself can be used as a selective vector: uncut or religated pMT416 will preclude growth while plasmids with inserts in the barnase gene will allow the cells to survive. The entire pUC polylinker was inserted into the barnase gene in place of the Val-36 codon. This insert of nineteen largely hydrophilic amino acids does not prevent the lethal effect of full expression of the gene. The resulting plasmid, pMT440, is a generally useful selective cloning vector representing the "kill-the-rest" approach.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790592     DOI: 10.1007/s004380050825

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  3 in total

1.  Modern Technologies for Creating Synthetic Antibodies for Clinical application.

Authors:  S M Deyev; E N Lebedenko
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

Review 2.  Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology.

Authors:  Olga Shilova; Polina Kotelnikova; Galina Proshkina; Elena Shramova; Sergey Deyev
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

3.  Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.

Authors:  Evelina Edelweiss; Taras G Balandin; Julia L Ivanova; Gennady V Lutsenko; Olga G Leonova; Vladimir I Popenko; Alexander M Sapozhnikov; Sergey M Deyev
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.